Sunday, April 28, 2024 4/28/2024

Improving Retention across the OUD Service Cascade upon Re-entry from Jail using Recovery Management Checkups

Award Number: UG1DA050065
ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE
OPDIV: NIH
AWARD CLASS: COOPERATIVE AGREEMENT
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By Issue Date FY or Funding FY:

View Award Abstract

7. Abstract Jails provide an optimal setting for intervening with individuals with opioid use disorders (OUD), given the high volume of offenders with OUD, and their high risk of relapse to opioids following their release to the community. It is imperative that individuals with OUD are linked to community-based medication assisted treatment (MAT) upon their re-entry, as well as receive support for their ongoing treatment retention and recovery. The proposed experiment will test an adapted version of an evidence-based intervention, the Recovery Management Checkups (RMC) model, which provides quarterly check-ups and assistance with treatment retention and re-linkage as indicated at the quarterly check-ups. The RMC-Adapted will adjust the frequency and intensity of check-ups based on the individual’s assessed need for treatment, thereby reducing (or lengthening) the time between check-ups for those with (or without) indicators of treatment need. The proposed experiment will compare treatment linkage and retention rates as well as public health and public safety outcomes of 750 male and female offenders randomly assigned to 1 of 3 groups upon release from jail: a) a re-entry as usual (control), b) the original RMC, and c) a RMC-Adaptive version tailored to the participant’s need for treatment. The study will be conducted in collaboration with 6 county jails in Illinois and the MAT providers that currently provide pre- and post-release MAT to offenders with OUD. Pre-release, participants will be screened for history of OUD and eligibility for MAT. All participants will receive research follow-up interviews quarterly for 2 years, which will also include urine testing and records checks (treatment, mortality, recidivism). The study aims are to evaluate: (1) the direct effects of RMC and/or RMC-Adaptive on the OUD service cascade of care (initiation, engagement, retention, re-linkage, and months of MAT participation); (2) the indirect effects of RMC and/or RMC-Adaptive (via months of MAT participation) on public health outcomes (days of opioid use, OUD symptoms, quality of life and the cost of health-care utilization); (3) the indirect effects of RMC and/or RMC-Adaptive (via months of MAT and public health outcomes) on public safety outcomes (illegal activity, re-arrest, re-incarceration, and cost of crime); and (4) the incremental costs and cost-effectiveness of the control vs. RMC vs. RMC-Adaptive in terms of both public health outcomes (days of opioid use, quality adjusted life years [QALYs], cost-of-health-care utilization) and public safety outcomes (re-incarceration and cost of crime). The study will determine if tailoring the checkups to individual’s need for treatment leads to more efficient targeting of resources to those in need, reduces the intervention burden on those with lower need, and results in an improved overall effectiveness and cost-effectiveness of RMC checkups.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2023 ( Subtotal = $1,822,250 )
2023	2023	CHESTNUT HEALTH SYSTEMS INC	1003 MARTIN LUTHER KING DR	BLOOMINGTON	IL	61701	MCLEAN	USA	Drug Abuse and Addiction Research Programs	000	5	4/28/2023	NON-COMPETING CONTINUATION	$1,822,250
														Subtotal = $1,822,250

Issue Date FY: 2022 ( Subtotal = $1,841,136 )
2022	2022	CHESTNUT HEALTH SYSTEMS INC	1003 MARTIN LUTHER KING DR	BLOOMINGTON	IL	61701	MCLEAN	USA	Drug Abuse and Addiction Research Programs	001	4	8/30/2022	NON-COMPETING CONTINUATION	$0
2022	2022	CHESTNUT HEALTH SYSTEMS, INC.	1003 MARTIN LUTHER KING DR	BLOOMINGTON	IL	61701	MCLEAN	USA	Drug Abuse and Addiction Research Programs	000	4	4/29/2022	NON-COMPETING CONTINUATION	$1,841,136
2022	2022	CHESTNUT HEALTH SYSTEMS INC	1003 MARTIN LUTHER KING DR	BLOOMINGTON	IL	61701	MCLEAN	USA	Drug Abuse and Addiction Research Programs	002	4	9/20/2022	NON-COMPETING CONTINUATION	$0
														Subtotal = $1,841,136

Issue Date FY: 2021 ( Subtotal = $1,860,072 )
2021	2021	CHESTNUT HEALTH SYSTEMS, INC.	1003 MARTIN LUTHER KING DR	BLOOMINGTON	IL	61701	MCLEAN	USA	Drug Abuse and Addiction Research Programs	000	3	5/5/2021	NON-COMPETING CONTINUATION	$1,860,072
														Subtotal = $1,860,072

Issue Date FY: 2020 ( Subtotal = $1,898,993 )
2020	2020	CHESTNUT HEALTH SYSTEMS, INC.	1003 MARTIN LUTHER KING DR	BLOOMINGTON	IL	61701	MCLEAN	USA	Drug Abuse and Addiction Research Programs	000	2	4/15/2020	NON-COMPETING CONTINUATION	$1,898,993
2020	2020	CHESTNUT HEALTH SYSTEMS, INC.	1003 MARTIN LUTHER KING DR	BLOOMINGTON	IL	61701	MCLEAN	USA	Drug Abuse and Addiction Research Programs	003	2	6/1/2020	NON-COMPETING CONTINUATION	$0
2020	2020	CHESTNUT HEALTH SYSTEMS, INC.	1003 MARTIN LUTHER KING DR	BLOOMINGTON	IL	61701	MCLEAN	USA	Drug Abuse and Addiction Research Programs	002	2	5/14/2020	NON-COMPETING CONTINUATION	$0
2020	2019	CHESTNUT HEALTH SYSTEMS, INC.	1003 MARTIN LUTHER KING DR	BLOOMINGTON	IL	61701	MCLEAN	USA	Drug Abuse and Addiction Research Programs	001	1	5/14/2020	NEW	$0
														Subtotal = $1,898,993

Issue Date FY: 2019 ( Subtotal = $1,846,711 )
2019	2019	CHESTNUT HEALTH SYSTEMS, INC.	1003 MARTIN LUTHER KING DR	BLOOMINGTON	IL	61701	MCLEAN	USA	Drug Abuse and Addiction Research Programs	000	1	7/15/2019	NEW	$1,846,711
														Subtotal = $1,846,711

Grand Total All Awards = $9,269,162

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Improving Retention across the OUD Service Cascade upon Re-entry from Jail using Recovery Management Checkups

Award Number: UG1DA050065

ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE

OPDIV: NIH

AWARD CLASS: COOPERATIVE AGREEMENT

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer